Singapore: Impax Laboratories announced that it has agreed to buy private pharmaceutical companies Tower Holdings Inc an...
Singapore: Taiwan-based drug delivery company, SHL, signed a memorandum of understanding (MoU) with the National Taipei ...
Singapore: While consumers are demanding food companies to specify the genetically modified ingredients of the food, the...
Singapore: UK-based Ergomed providing specialised services to the pharmaceutical industry and the development of new dru...
Singapore: Taiwan based TWi Pharmaceuticals has received US FDA and Taiwan FDA approval of a protocol for a Phase II cli...
Singapore: BioBusiness Asia concluded in Taiwan on July 18, 2013, with a message that the global biotech fraternity need...
Singapore: Taipei-based healthcare company, Show 101 Royal Health Care, announced its partnership with Aerospace Industr...
Singapore: A US government investigation started at the request of ResMed against Taiwanese manufacturer Apex Medical ha...
Singapore: Researchers at the National University of Taiwan have developed a new 'smart tooth' that monitors an individu...
Singapore: Amid sporadic avian flu cases still surfacing in Asia, a new strain H5N3 has been now identified by the Taiwa...
Singapore: Taiwan-based Ssu Cheng Biotech has signed an exclusive agreement with the Council of Agriculture (COA) in Tai...
Singapore: The Mainland Affairs Council (MAC) recently announced that Taiwan and China have reached a concrete consensus...
Singapore: Taiwan-based biopharmaceutical firm, ScinoPharm, had a sluggish revenue in 2014, generated $135 million (unau...
Singapore: Scientists at the Division of Hematology and Oncology of Taipei Veterans General Hospital's Department of Ped...
Singapore: The Taiwan Bio-Development Foundation, a non-profit organization that focuses to develop the nation's biotech...
Singapore: In a bid to improve healthcare facilities in Sierra Leone, the Taiwan-based Buddhist Tzu chi Foundation has o...
Singapore: A study presented at the European Respiratory Society Congress at Munich, Germany, by Novartis highlighted th...
Singapore: Taiwan-based TWi Biotechnology, has completed the patient enrollment in a phase II trial of AC-201 for Gout F...
